The estimated Net Worth of Mary E Foley is at least $1.18 Milion dollars as of 14 August 2012. Mary Foley owns over 5,745 units of Omnicell stock worth over $1,038,202 and over the last 18 years Mary sold OMCL stock worth over $136,919.
Mary has made over 11 trades of the Omnicell stock since 2006, according to the Form 4 filled with the SEC. Most recently Mary exercised 5,745 units of OMCL stock worth $53,141 on 14 August 2012.
The largest trade Mary's ever made was exercising 21,132 units of Omnicell stock on 13 March 2012 worth over $250,837. On average, Mary trades about 3,945 units every 116 days since 2006. As of 14 August 2012 Mary still owns at least 24,105 units of Omnicell stock.
You can see the complete history of Mary Foley stock trades at the bottom of the page.
Mary's mailing address filed with the SEC is C/O OMNICELL, INC., 1201 CHARLESTON ROAD, MOUNTAIN VIEW, CA, 94043.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps a Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: